Skip to main content
OpenTrials

Clinical trial condition

The Role of Molecular Residual Disease in the Treatment Strategy and Prognosis Prediction of Pancreatic Cancer Patients Undergoing Adjuvant Therapy

Explore clinical trials studying The Role of Molecular Residual Disease in the Treatment Strategy and Prognosis Prediction of Pancreatic Cancer Patients Undergoing Adjuvant Therapy. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

The Role of Molecular Residual Disease in the Treatment Strategy and Prognosis Prediction of Pancreatic Cancer Patients Undergoing Adjuvant Therapy trial results

Active, Not Recruiting

MRD in PAAD Adjuvant Therapy

NCT06867146

Conditions
Adjuvant Therapy, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View Trial Details

Related conditions